Implementing Geriatric Assessment for Dose Optimization of Cyclin-dependent Kinase (CDK) 4/6-inhibitors in Older Breast Cancer Patients

Clinical trial NCT06044623 · RECRUITING

Trial details

NCT number: NCT06044623
Sponsor: Region Örebro County
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Metastatic Breast Cancer Advanced Breast Cancer Quality of Life Toxicity Older Patients

Start date: 2024-04-01
Primary completion: 2028-10-31
Enrollment: 495

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.